Literature DB >> 19189321

Nmp4/CIZ suppresses parathyroid hormone-induced increases in trabecular bone.

Alexander G Robling1, Paul Childress, Jun Yu, Jessica Cotte, Aaron Heller, Binu K Philip, Joseph P Bidwell.   

Abstract

The nucleocytoplasmic shuttling transcription factor Nmp4/CIZ (nuclear matrix protein 4/cas interacting zinc finger protein) is a ubiquitously expressed protein that regulates both cytoplasmic and nuclear activities. In the nucleus, Nmp4/CIZ represses transcription of genes crucial to osteoblast differentiation and genes activated by various anabolic stimuli, including parathyroid hormone (PTH). We investigated the role of Nmp4/CIZ in the PTH-induced increase in bone by engineering mice with loss-of-function mutations in the Nmp4/CIZ gene, and treating 10-week-old female mice with anabolic doses of human PTH (1-34) at 30 microg/kg/day, 7 day/week, for 7 weeks or vehicle control. The untreated, baseline phenotype of the Nmp4-null mice between 8 and 16 weeks of age included a modest but significant increase in bone mineral density (BMD) and bone mineral content (BMC) compared to wild-type (WT) mice. Type I collagen mRNA expression was moderately elevated in the femurs of the Nmp4-null mice. The Nmp4 mutant alleles decreased body weight by 4% when expressed on a mixed background but the same alleles on a pure B6 background yielded a significant, 15% increase in body weight among the KO mice, compared to their WT controls. Hormone treatment equally enhanced BMD and BMC over vehicle-treated mice in both the WT and Nmp4-null groups but Nmp4-KO mice exhibited a significantly greater PTH-induced acquisition of femoral trabecular bone as compared to WT mice. These data support our hypothesis that Nmp4/CIZ is a transcriptional attenuator that suppresses osteoid synthesis and PTH-mediated acquisition of cancellous bone. J. Cell. Physiol. 219: 734-743, 2009. (c) 2009 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19189321      PMCID: PMC2746029          DOI: 10.1002/jcp.21717

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  36 in total

1.  The ternary IGF complex influences postnatal bone acquisition and the skeletal response to intermittent parathyroid hormone.

Authors:  Shoshana Yakar; Mary L Bouxsein; Ernesto Canalis; Hui Sun; Vaida Glatt; Caren Gundberg; Pinchas Cohen; David Hwang; Yves Boisclair; Derek Leroith; Clifford J Rosen
Journal:  J Endocrinol       Date:  2006-05       Impact factor: 4.286

2.  Overexpression of the transcriptional factor Runx2 in osteoblasts abolishes the anabolic effect of parathyroid hormone in vivo.

Authors:  Didier Merciris; Caroline Marty; Corinne Collet; Marie-Christine de Vernejoul; Valerie Geoffroy
Journal:  Am J Pathol       Date:  2007-05       Impact factor: 4.307

Review 3.  Playing with bone and fat.

Authors:  Jeffrey M Gimble; Sanjin Zvonic; Z Elizabeth Floyd; Moustapha Kassem; Mark E Nuttall
Journal:  J Cell Biochem       Date:  2006-05-15       Impact factor: 4.429

4.  Two promoters control the mouse Nmp4/CIZ transcription factor gene.

Authors:  Marta Alvarez; Rita Shah; Simon J Rhodes; Joseph P Bidwell
Journal:  Gene       Date:  2005-01-21       Impact factor: 3.688

5.  CREM deficiency in mice alters the response of bone to intermittent parathyroid hormone treatment.

Authors:  Fei Liu; Sun-Kyeong Lee; Douglas J Adams; Gloria A Gronowicz; Barbara E Kream
Journal:  Bone       Date:  2007-02-01       Impact factor: 4.398

6.  Deficiency of CIZ, a nucleocytoplasmic shuttling protein, prevents unloading-induced bone loss through the enhancement of osteoblastic bone formation in vivo.

Authors:  K Hino; T Nakamoto; A Nifuji; M Morinobu; H Yamamoto; Y Ezura; M Noda
Journal:  Bone       Date:  2007-02-14       Impact factor: 4.398

7.  PTH-induced actin depolymerization increases mechanosensitive channel activity to enhance mechanically stimulated Ca2+ signaling in osteoblasts.

Authors:  Jinsong Zhang; Kimberly D Ryder; Jody A Bethel; Raymund Ramirez; Randall L Duncan
Journal:  J Bone Miner Res       Date:  2006-11       Impact factor: 6.741

Review 8.  New mechanisms and targets in the treatment of bone fragility.

Authors:  T John Martin; Ego Seeman
Journal:  Clin Sci (Lond)       Date:  2007-01       Impact factor: 6.124

Review 9.  Molecular and cellular mechanisms of the anabolic effect of intermittent PTH.

Authors:  Robert L Jilka
Journal:  Bone       Date:  2007-04-06       Impact factor: 4.398

10.  Proteasomal degradation of Runx2 shortens parathyroid hormone-induced anti-apoptotic signaling in osteoblasts. A putative explanation for why intermittent administration is needed for bone anabolism.

Authors:  Teresita Bellido; A Afshan Ali; Lilian I Plotkin; Qiang Fu; Igor Gubrij; Paula K Roberson; Robert S Weinstein; Charles A O'Brien; Stavros C Manolagas; Robert L Jilka
Journal:  J Biol Chem       Date:  2003-10-01       Impact factor: 5.157

View more
  20 in total

1.  Improving Combination Osteoporosis Therapy in a Preclinical Model of Heightened Osteoanabolism.

Authors:  Yu Shao; Selene Hernandez-Buquer; Paul Childress; Keith R Stayrook; Marta B Alvarez; Hannah Davis; Lilian I Plotkin; Yongzheng He; Keith W Condon; David B Burr; Stuart J Warden; Alexander G Robling; Feng-Chun Yang; Ronald C Wek; Matthew R Allen; Joseph P Bidwell
Journal:  Endocrinology       Date:  2017-09-01       Impact factor: 4.736

2.  Immortalization and characterization of osteoblast cell lines generated from wild-type and Nmp4-null mouse bone marrow stromal cells using murine telomerase reverse transcriptase (mTERT).

Authors:  Marta B Alvarez; Paul Childress; Binu K Philip; Rita Gerard-O'Riley; Michael Hanlon; Brittney-Shea Herbert; Alexander G Robling; Fredrick M Pavalko; Joseph P Bidwell
Journal:  J Cell Physiol       Date:  2012-05       Impact factor: 6.384

Review 3.  Functional impairment of bone formation in the pathogenesis of osteoporosis: the bone marrow regenerative competence.

Authors:  Joseph P Bidwell; Marta B Alvarez; Mark Hood; Paul Childress
Journal:  Curr Osteoporos Rep       Date:  2013-06       Impact factor: 5.096

Review 4.  Molecular genetic studies of gene identification for osteoporosis: the 2009 update.

Authors:  Xiang-Hong Xu; Shan-Shan Dong; Yan Guo; Tie-Lin Yang; Shu-Feng Lei; Christopher J Papasian; Ming Zhao; Hong-Wen Deng
Journal:  Endocr Rev       Date:  2010-03-31       Impact factor: 19.871

Review 5.  Nmp4/CIZ closes the parathyroid hormone anabolic window.

Authors:  Joseph P Bidwell; Paul Childress; Marta B Alvarez; Mark Hood; Yongzheng He; Fredrick M Pavalko; Melissa A Kacena; Feng-Chun Yang
Journal:  Crit Rev Eukaryot Gene Expr       Date:  2012       Impact factor: 1.807

6.  Nmp4/CIZ suppresses the response of bone to anabolic parathyroid hormone by regulating both osteoblasts and osteoclasts.

Authors:  Paul Childress; Binu K Philip; Alexander G Robling; Angela Bruzzaniti; Melissa A Kacena; Nicoletta Bivi; Lilian I Plotkin; Aaron Heller; Joseph P Bidwell
Journal:  Calcif Tissue Int       Date:  2011-05-24       Impact factor: 4.333

7.  Nmp4/CIZ inhibits mechanically induced beta-catenin signaling activity in osteoblasts.

Authors:  Zhouqi Yang; Joseph P Bidwell; Suzanne R Young; Rita Gerard-O'Riley; Haifang Wang; Fredrick M Pavalko
Journal:  J Cell Physiol       Date:  2010-05       Impact factor: 6.384

8.  Loss of Nmp4 optimizes osteogenic metabolism and secretion to enhance bone quality.

Authors:  Yu Shao; Emily Wichern; Paul J Childress; Michele Adaway; Jagannath Misra; Angela Klunk; David B Burr; Ronald C Wek; Amber L Mosley; Yunlong Liu; Alexander G Robling; Nickolay Brustovetsky; James Hamilton; Kylie Jacobs; Deepak Vashishth; Keith R Stayrook; Matthew R Allen; Joseph M Wallace; Joseph P Bidwell
Journal:  Am J Physiol Endocrinol Metab       Date:  2019-01-15       Impact factor: 4.310

9.  Nmp4/CIZ: road block at the intersection of PTH and load.

Authors:  Paul Childress; Alexander G Robling; Joseph P Bidwell
Journal:  Bone       Date:  2009-09-18       Impact factor: 4.398

10.  Nuclear Matrix Protein 4 Is a Novel Regulator of Ribosome Biogenesis and Controls the Unfolded Protein Response via Repression of Gadd34 Expression.

Authors:  Sara K Young; Yu Shao; Joseph P Bidwell; Ronald C Wek
Journal:  J Biol Chem       Date:  2016-04-29       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.